- Everyday Alpha
- Posts
- Healthcare’s Hidden Compounder: This Growth Stock Is Riding the Grey Wave
Healthcare’s Hidden Compounder: This Growth Stock Is Riding the Grey Wave
Hello and welcome to Everyday Alpha, the daily newsletter showcasing a different stock opportunity every day the market is open. We give you laser-focused content to save you time and energy so you can make educated investment decisions quickly.
Steady Performers (Sponsored)
Every strong portfolio starts with a reliable core — and this new report may help investors build exactly that.
“7 Stocks to Buy and Hold Forever” highlights a group of companies with a track record of steady performance, strong fundamentals, and long-term growth potential.
These stocks were chosen for a reason — and could help lay the groundwork for a strategy built to outlast short-term swings.
Never Miss a Stock Alert Again!
We now send our daily picks via text too — so you’ll get the same high-conviction ideas, even if you miss the email.
The Ensign Group, Inc.
July 15 – Pre‑market
Ticker: ENSG | Sector: Medical Care Facilities | Market Cap: ~ $8.36B
30‑Second Take
Why now? Life expectancy in the US sits at 78.4 years from birth, but while Americans are living longer, they aren’t enjoying good health into old age.
For The Ensign Group, this longevity, coupled with a growing demand for senior healthcare services, is a winning formula.
The nursing and senior living operator is expanding rapidly to leverage its potential.
At the start of July, it confirmed it had acquired a 120-bed skilled nursing facility in Boise, Idaho, to further grow its footprint in the northwest, along with a 124-bed skilled nursing facility in Duncanville, Texas.
These additions bring its portfolio to 348 healthcare operations across 17 states, with additional expansion expected over the coming months.
Trade Setup
Time frame: Swing to medium-term
Edge type: Momentum breakout
Snapshot Table
Metric | Value | Current Stance |
|---|---|---|
Price | $145.32 | Above average |
52‑week range | $118.73 - $158.45 | Above average |
Short interest | 3.73% | Average |
Next catalyst | Q2 earnings release, expected late July |
Chart
5-Day Synopsis: While ENSG stock is up 9.38% for the year to date, the last five trading sessions have been unsettled with a 1.52% decline.
Although the drop is modest, the fall does create a sliver of opportunity for investors interested in adding a solid growth stock to their portfolio.
Bull Case
Core thesis: Founded in 1999, The Ensign Group provides a range of post-acute care services, including assisted living, skilled nursing, and rehabilitative care.
It has more than a dozen affiliates with locations in 17 states. It strives to provide high-quality, resident-centered care at a lower attendant cost.
The Group’s current portfolio spans 348 facilities, with that number anticipated to grow throughout 2025.
Catalysts: The Ensign Group is an outperformer in the Medical Care sector.
It reported a record-breaking first quarter, with revenue increasing by 27.9%, GAAP diluted earnings increasing by 15.1%, and adjusted net income growing by 18.0% year-on-year.
This was matched by strong clinical outcomes and a profitable growth strategy, with 47 new operations added since 2024.
Many of those new facilities are already profitable, creating additional growth potential.
The company also has high levels of liquidity, with $282.7 million cash on hand and $572.1 million of available capacity under its line of credit.
Valuation upside: The valuation upside for ENSG stock is $177.00. The current stock price is just shy of the lowest analyst price target of $155.00.
The average price target is currently $165.17.
Technical tailwind: ENSG has performed strongly this year.
With steady institutional accumulation and support from rising 50 and 200-day moving averages, the stock appears to be setting up for a move higher.
AI Stocks (Sponsored)
While headlines focus on the same overhyped AI names, a bigger opportunity is taking shape — and it’s flying under the radar.
A new report reveals 9 AI companies with real U.S. operations, accelerating revenue, and deep AI integration. These aren’t speculative plays — they’re positioned to benefit from a massive shift in how and where AI is being built.
This free guide includes:
A chip supplier poised to fuel U.S. AI manufacturing
A cloud provider set to expand under new policy changes
A data firm with potential government contracts on deck
The early window on these opportunities may be closing — now’s the time to see what’s coming next.
Bear Case
Key risk: The Ensign Group is heavily reliant on revenue generated via the Medicare and Medicaid programs.
This makes policy change a key risk, as government cost-cutting measures or political shifts may lead to lower reimbursement rates.
Any change in those rates could weigh on profitability. The lack of skilled senior care personnel is of similar concern.
Chronic and ongoing shortages in the sector could push up staffing costs, again weighing on profits.
Macro/sector headwinds: Skilled nursing is a heavily regulated area.
Any tightening of compliance standards or enforcement could increase costs to the business or see underperforming facilities threatened with closure.
Competitive threat: The Group’s biggest threat isn’t posed by a single competitor but by larger hospitals and health systems that could choose to integrate post-acute care by offering skilled nursing in-house, therefore removing the need for standalone operators like Ensign.
Crowded-trade concern: There’s a high level of institutional ownership, and while ENSG has consistently outperformed and has strong fundamentals, it is priced for perfection.
There’s very little margin for error if growth stalls or a single regulatory shoe drops.
Quick Checklist
✅ Thesis still valid after today’s close
✅ Volume confirms move above key levels
✅ Catalyst date double-checked (July 14, 2025)
Deep‑Dive Links
That’s all for today’s Everyday Alpha. We’ll have a new pick for you every morning before the market opens, so stay tuned!
Best Regards,
—Noah Zelvis
Everyday Alpha